St. Jude Foresees Close-Out Letter Soon
This article was originally published in The Silver Sheet
Executive Summary
St. Jude Medical says FDA has completed a re-inspection of its Sylmar, Calif., cardiac rhythm management device facility that drew an FDA warning letter in 2013, and it remains on track to have the letter closed out this year.